C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study

Martin Rutter, Martin K. Rutter, James B. Meigs, Lisa M. Sullivan, Ralph B. D'Agostino, Peter W F Wilson

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background - Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited. Methods and Results - We assessed the cross-sectional relations of CRP to the MetS (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III definition) in 3037 subjects (1681 women; mean age, 54 years) and the utility of CRP and the MetS to predict new CVD events (n=189) over 7 years. MetS (≥3 of 5 traits) was present in 24% of subjects; mean age-adjusted CRP levels for those with 0, 1, 2, 3, 4, or 5 MetS traits were 2.2, 3.5, 4.2, 6.0, or 6.6 mg/L, respectively (P trend
    Original languageEnglish
    Pages (from-to)380-385
    Number of pages5
    JournalCirculation
    Volume110
    Issue number4
    DOIs
    Publication statusPublished - 27 Jul 2004

    Keywords

    • C-reactive protein
    • Cardiovascular diseases
    • Insulin
    • Prognosis
    • Risk factors

    Fingerprint

    Dive into the research topics of 'C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study'. Together they form a unique fingerprint.

    Cite this